ABUS vs KO
Arbutus Biopharma Corp (ABUS) versus The Coca-Cola Company (KO) — a side-by-side from cached financials, not a winner call.
Arbutus Biopharma Corp (ABUS) is a biotechnology company listed on NASDAQ.
The Coca-Cola Company (KO) is a beverages - non-alcoholic company listed on NYSE. It is led by James Quincey.
Latest reported ABUS revenue for 2024-12-31 was $6.2M. Net income was -$69.9M. Revenue was down 66.0% from 2023-12-31 to 2024-12-31. ABUS currently screens at market cap $883.0M and trailing P/E 5.4.
Latest reported KO revenue for 2025-12-31 was $47.94B. Net income was $13.11B. Revenue was up 1.9% from 2024-12-31 to 2025-12-31. KO currently screens at market cap $343.90B and trailing P/E 25.1.
ABUS currently screens at market cap $883.0M and trailing P/E 5.4. KO currently screens at market cap $343.90B and trailing P/E 25.1.
Not investment advice. Open the ABUS and KO stock pages for the full models.
Not investment advice.